MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-DL-04-0004800
Nilsan Pharmaceuticals Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹17.12 Cr
▼ 9% YoY
Net profit · FY 2025
₹35.15 Lakh
Net margin 2.1%
EBITDA · FY 2025
₹1.34 Cr
EBITDA margin 7.8%
Authorised capital
₹20 Lakh
Registered with MCA
Paid-up capital
₹20 Lakh
Issued & subscribed
Open charges
₹5.42 Cr
Secured borrowings
Company age
30 yrs
Est. 1996
Directors on board
2
As per MCA filings
About Nilsan Pharmaceuticals Private Limited
Data last updated:
Nilsan Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 18 July 1996 and has been in existence for over 30 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74210DL1996PTC080481. Its GSTIN is 07AABCN9603L1Z8 (Delhi).
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹20 Lakh. It was formerly known as Nelcom Pharma Private Limited. It is led by directors Kavita Garg and Sandeep Kumar Garg.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Unit No B Basement Floor Vardhman Grand Plaza Manglam Palace S, Ector 3, New Delhi, Delhi, India – 110085.
As per the financials filed for FY 2025, the company reported a revenue of ₹17.12 Cr, a decline of 9% compared to the previous year. For the same year it recorded a net profit of ₹35.15 Lakh (net margin 2.1%) and EBITDA of ₹1.34 Cr (EBITDA margin 7.8%). Revenue has declined at a compounded annual rate (CAGR) of 8% over three years and 3% over five years.
The company is associated with 1 brand: Nilsan Pharmaceuticals. As per MCA filings, the company has open charges of ₹5.42 Cr on record. Court records list 23 cases involving the company, including 22 filed by the company and 1 filed against it; 9 cases are pending.
Nilsan Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-04-0004800). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website nilsanpharmaceuticals.com.
Company details
CIN U74210DL1996PTC080481
Registration Number 080481
Incorporation Date 18 July 1996
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-DL-04-0004800
Key People
Kavita Garg Director Sandeep Kumar Garg Director Recognitions & Rankings of Nilsan Pharmaceuticals
Contact details
Nilsan Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its website is nilsanpharmaceuticals.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressUnit No B Basement Floor Vardhman Grand Plaza Manglam Palace S, Ector 3, New Delhi, Delhi, India – 110085
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Nilsan Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Nilsan Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Nilsan Pharmaceuticals operates one associated brand: Nilsan Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures and markets a wide range of prescription, over-the-counter medications, nutraceuticals, and cosmeceuticals. | nilsanpharmaceuticals.com |
Business activity
The main business activity of Nilsan Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Nilsan Pharmaceuticals Private Limited, buy the company report.
Financials of Nilsan Pharmaceuticals Private Limited
FY 2025 filings availableNilsan Pharmaceuticals Private Limited reported revenue of ₹17.12 Cr (down 9% YoY) for FY 2025.
Revenue · FY 2025
₹17.12 Cr ▼ 9%
Net profit · FY 2025
₹35.15 Lakh margin 2.1%
EBITDA · FY 2025
₹1.34 Cr margin 7.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 9%
3 years · compounded
▼ 8%
5 years · compounded
▼ 3%
EBITDA CAGR growth
1 year
▲ 17%
3 years · compounded
▲ 15%
5 years · compounded
▲ 34%
Revenue has declined at a compounded annual rate (CAGR) of 3% over five years, including a 9% fall in the latest year. EBITDA rose 17% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.34 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹35.15 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.8% | ||||
| Net Profit Margin | 2.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Nilsan Pharmaceuticals Private Limited, buy the company report.
Board of directors of Nilsan Pharmaceuticals Private Limited
Nilsan Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kavita Garg | Director | 01 Oct 2013 | 13 Years 0 Months | Current |
| Sandeep Kumar Garg | Director | 18 Jul 1996 | 30 Years 3 Months | Current |
Peer comparison
Nilsan Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Bhushan Pharmaceuticals Private Limited | ₹17.18 Cr (FY 2024) | 17.0% | Delhi, India | |||
| Menezes Pharmaceuticals Limited | ₹17.15 Cr (FY 2025) | 79.0% | Panjim, Goa, India | |||
| Invision Medi Sciences Private Limited | ₹17.12 Cr (FY 2024) | -5.0% | Bengaluru, Karnataka, India | |||
| Nilsan Pharmaceuticals Private Limitedthis company | ₹17.12 Cr (FY 2025) | ₹35.15 Lakh | 2.1% | -9.0% | New Delhi, Delhi, India | |
| Glee Biotech Limited | ₹17.11 Cr (FY 2024) | -7.0% | New Delhi, Delhi, India | |||
| Octane Biotech Private Limited | ₹17.08 Cr (FY 2025) | 1.0% | Lucknow, Uttar Pradesh, India |
To see the full peer comparison of Nilsan Pharmaceuticals Private Limited, buy the company report.
Auditor
Nilsan Pharmaceuticals Private Limited is audited by Rahul Singla for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Rahul Singla | FY 2023 | 525681 |
Shareholding
The shareholding of Nilsan Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Nilsan Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹5.42 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Aug 2024 | 100980748 | Others | ₹4.47 Cr | Open | |
| 28 Jun 2018 | 100230569 | Others | ₹90 Lakh | Open | |
| 20 Jul 1998 | 90034757 | Punjab & Sind Bank | ₹5 Lakh | Open |
Total charge records: 3 View all charges
Legal cases
Nilsan Pharmaceuticals Private Limited has 23 court cases on record: 22 filed by Nilsan Pharmaceuticals, 1 filed against it. 9 cases are pending and 14 are disposed.
Total cases
23
Filed by the company
22
Filed against the company
1
Pending
9
Disposed
14
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 23 | 1 | 9 |
Cases on record (5 of 23)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, North West, Delhi | Cheque dishonour complaint | Filed by the company against an individual | Pending |
| District court, North West, Delhi | Cheque dishonour complaint | Filed by the company against an individual | Pending |
| District court, North West, Delhi | Cheque dishonour complaint | Filed by the company against an individual | Pending |
| District court, North West, Delhi | Cheque dishonour complaint | Filed by the company against Ms Shri Shyam Pharma | Pending |
| District court, North West, Delhi | Cheque dishonour complaint | Filed by the company against Ms Faridabad Pharmaceuticals | Pending |
To see the full case history of Nilsan Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nilsan Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Nilsan Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AABCN9603L1Z8 | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Nilsan Pharmaceuticals Private Limited, buy the company report.
Recent activity
Nilsan Pharmaceuticals Private Limited has 4 board changes on record since 1996: 2 appointments and 2 cessations. The latest: Kavita Garg ceased to be Additional Director on 30 Nov 2019.
AGM
Nilsan Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Nilsan Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Charges
A charge with Others amounted to Rs. 447.00 Lakh with Charge ID 100980748 was registered on 28 Aug 2024.
Ceased
Kavita Garg ceased to be Additional Director.
Charges
A charge with Others amounted to Rs. 90.00 Lakh with Charge ID 100230569 was registered on 28 Jun 2018.
Ceased
Ravinder Kumar Mittal ceased to be Director.
Appointed
Kavita Garg was appointed as Director.
Charges
A charge with Punjab & Sind Bank amounted to Rs. 5.00 Lakh with Charge ID 90034757 was registered on 20 Jul 1998.
Appointed
Sandeep Kumar Garg was appointed as Director.
Incorporation
18 Jul 1996
Nilsan Pharmaceuticals Private Limited was registered on 18 Jul 1996 with Roc Delhi & aged 30 years 3 months as per MCA records.
Frequently asked questions
Nilsan Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 18 July 1996 (30+ years old) and is registered under CIN U74210DL1996PTC080481.
Nilsan Pharmaceuticals has 2 current directors:
- Kavita Garg - Director
- Sandeep Kumar Garg - Director
The latest financial statements of Nilsan Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Nilsan Pharmaceuticals is 07AABCN9603L1Z8, registered in Delhi.
The CIN (Corporate Identification Number) of Nilsan Pharmaceuticals is U74210DL1996PTC080481. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nilsan Pharmaceuticals has 23 court cases on record: 22 filed by the company and 1 filed against it. 9 are pending.
Nilsan Pharmaceuticals was incorporated on 18 July 1996, making it 30+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Nilsan Pharmaceuticals by revenue are Bhushan Pharmaceuticals Private Limited, Menezes Pharmaceuticals Limited, Invision Medi Sciences Private Limited, Glee Biotech Limited, Octane Biotech Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading).
Kavita Garg ceased to be Additional Director on 30 Nov 2019. Ravinder Kumar Mittal ceased to be Director on 04 Oct 2014. Kavita Garg was appointed as Director on 01 Oct 2013. Nilsan Pharmaceuticals has 4 board changes on record in total.
Yes, Nilsan Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-DL-04-0004800).
Nilsan Pharmaceuticals can be reached through the website nilsanpharmaceuticals.com. Its registered office is in New Delhi, Delhi, India.